Welcome to Sabine Dandiguian

We are delighted to welcome Sabine Dandiguian, Managing Partner at Jeito Capital to the NMD Pharma Board as Non-Executive Director. Jeito Capital, one of the largest healthcare funds in Europe, recently led our €35 million new financing round and is joining our roster of existing investors.

Sabine Dandiguian has over 30 years of experience in the pharmaceutical and medical devices industry. She serves on the Boards of SparingVision, Pulmocide and NMD Pharma as a representative of Jeito.

Prior to Jeito, she spent 20 years at Johnson & Johnson, notably becoming President of France at Janssen, then Managing Director of European emerging countries.

Sabine has been recognized as Chevalier de l’Ordre du Mérite, Chevalier de la Légion d’Honneur and is a member of the « Assemblée des 100 » of Institut Pasteur. She has been a member of W.I.T.H. (Women Innovating Together in Healthcare) association since its creation.